Danaher Co. (NYSE: DHR) was given a new $231.00 price target on by analysts at Robert W. Baird.
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight [Yahoo! Finance]
Is Danaher Corporation (DHR) the Best Medical Stock to Buy According to Billionaires? [Yahoo! Finance]
Oxford Nanopore inks infectious disease analysis pact with Cepheid [Yahoo! Finance]
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions [Yahoo! Finance]